Skip to main content
4SC AG logo

4SC AG — Investor Relations & Filings

Ticker · VSC ISIN · DE000A3E5C40 LEI · 391200QOKN7LGVP0RQ86 F Manufacturing
Open in API
Filings indexed 719 across all filing types
Latest filing 2012-06-29 Capital/Financing Update
Country DE Germany
Listing F VSC

About 4SC AG

https://www.4sc.com/

4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.

Recent filings

Filing Released Lang Actions
4SC AG: Volume of capital increase determined at 8,403,510 new shares, gross proceeds of EUR 12,605,265.00 expected
Capital/Financing Update Classification · 98% confidence The document is an 'Ad hoc announcement' dated June 29, 2012, detailing the determination of the volume of a capital increase, including the number of new shares (8,403,510) and expected gross proceeds (EUR 12,605,265.00). This announcement explicitly concerns fundraising and changes to the company's capital structure. This directly aligns with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple dividend notice (DIV). Since it is a specific announcement about a financing event, CAP is the most precise classification.
2012-06-29 English
Capital increase 4SC AG: subscription offer period ended, rump placement started
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated June 29, 2012, titled "4SC AG capital increase: subscription offer period ended, rump placement started." It explicitly discusses the mechanics of a cash capital increase, including subscription rights, pre-placement, rump placement, and the intended use of proceeds. This content directly relates to changes in the company's capital structure and fundraising activities. This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV).
2012-06-29 English
4 SC AG: Bekanntmachung der Einberufung zur Hauptversammlung am 06.08.2012 in Munchen mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 99% confidence The document is explicitly titled 'Einladung zur ordentlichen Hauptversammlung 2012' (Invitation to the Annual General Meeting 2012) and details the agenda (Tagesordnung) for the meeting scheduled for August 6, 2012. The agenda items include voting on management discharge, auditor appointment, remuneration system approval, and changes to authorized capital, all typical subjects for an AGM. The document is an announcement/invitation for the meeting itself, not the minutes or voting results. Therefore, it falls under the AGM Information category.
2012-06-28 German
Press Release: 4SC to present additional safety and efficacy data for cancer drug Resminostat from its Phase II SHELTER trial in liver cancer
Regulatory Filings Classification · 100% confidence The document is a press release dated June 28, 2012, announcing that 4SC AG will present additional safety and efficacy data for its cancer drug, Resminostat, from its Phase II SHELTER trial at the ESMO GI Cancer Meeting. It details preliminary clinical results (dose escalation, treatment durations, PFSR) and discusses future development plans, including discussions with regulatory agencies for a pivotal study. This content is characteristic of an announcement regarding clinical trial progress and scientific presentation, which falls under general corporate/investor communications. Since it is not a formal regulatory filing like a 10-K, a specific earnings release (ER), or a formal report (AR, IR), and it is primarily communicating scientific data updates, it best fits the 'Regulatory Filings' (RNS) category as a general corporate announcement, or potentially 'Investor Presentation' (IP) if it were the presentation itself, but as a press release detailing the presentation, RNS is the most appropriate general category for non-standard announcements. Given the context of clinical trial updates being released via press release, RNS is the best fit among the provided options, as it is a general regulatory/corporate announcement.
2012-06-28 English
Declaration of Voting Results & Voting Rights Announcements 2012
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections detailing the 'Veröffentlichung einer Stimmrechtsmitteilung' (Publication of a voting rights notification) according to German securities law (§ 26 Abs. 1 WpHG and § 25 Abs. 1 WpHG). It reports on the acquisition/disposal of shares by Santo Holding AG, crossing specific voting rights thresholds (5%, 10%, 15%, etc.). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes or, in this context, significant changes in voting power notifications.
2012-06-22 German
Declaration of Voting Results & Voting Rights Announcements 2012
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details changes in the voting rights held by Van Lanschot N.V. and its subsidiaries in 4 SC AG, crossing and falling below specific percentage thresholds (3% and 5%) as mandated by German Securities Trading Act (WpHG). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes or related notifications regarding voting power changes.
2012-06-22 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.